Amgen Inc (AMGN) has declared a quarterly dividend of $2.52 per share, payable to shareholders of record. This marks a 5.9% increase from the previous dividend of $2.38 per share.
The ex-dividend date is set for February 12, 2026, meaning investors must own shares before this date to receive the dividend. The payment date is scheduled for March 5, 2026.
With a dividend yield of 3.15%, Amgen continues to provide regular income to its shareholders. This increase reflects management's confidence in the company's financial position and commitment to returning capital to investors.
Amgen operates in the biotechnology sector, focusing on the discovery, development, manufacture, and marketing of human therapeutics. The company, headquartered in Thousand Oaks, California, employs approximately 28,000 people and has a market capitalization of $169.8 billion. The current P/E ratio stands at 24.24, with an EPS of 12.94.
Upcoming earnings are expected on August 3, 2026, with an estimated EPS of $5.86 and revenue of $9.5 billion. This update provides insight into Amgen's cash flow generation and capital allocation strategy, appealing to income-focused investors.